RAD — Radiopharm Theranostics Cashflow Statement
0.000.00%
Last trade - 00:00- AU$87.50m
- AU$56.47m
- AU$3.63m
- 14
- 22
- 86
- 35
Annual cashflow statement for Radiopharm Theranostics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | — | 0.009 | 1.7 | 4.9 | 0.8 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.033 | -9.91 | -23.2 | -23 | -36.6 |
| Capital Expenditures | — | -28.3 | -1.53 | 0 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | -0.04 | 0 | — | 1.77 |
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | -28.4 | -1.53 | 0 | 1.77 |
| Financing Cash Flow Items | — | -4.83 | -0.855 | -1.97 | -6.65 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.06 | 65.1 | 9.22 | 29.9 | 45.4 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.027 | 27 | -15.3 | 6.88 | 10.5 |